Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Operating Expenses | 4,000 | 3,179 | 2,632 | 0 | 2,211 |
| Operating Income | -4,000 | -3,179 | -2,632 | -1,508 | -2,211 |
| Other Income | -40 | -699 | -46 | 318 | 637 |
| Pre-tax Income | -4,040 | -3,878 | -2,678 | -1,190 | -1,574 |
| Income Tax | N/A | N/A | N/A | -400 | -640 |
| Net Income Continuous | -4,040 | -3,878 | -2,678 | N/A | -934 |
| Net Income | $-4,040 | $-3,878 | $-2,678 | $N/A | $-934 |
| EPS Basic Total Ops | -46.00 | -41.60 | -29.20 | -32.00 | -40.00 |
| EPS Basic Continuous Ops | -38.40 | -36.89 | -25.47 | N/A | -36.44 |
| EPS Diluted Total Ops | -46.00 | -41.60 | -29.20 | -32.00 | -40.00 |
| EPS Diluted Continuous Ops | -38.40 | -36.89 | -25.47 | N/A | -36.44 |
| EBITDA(a) | $-3,989 | $-2,570 | $-2,603 | $14 | $-2,211 |